TB Alliance Awarded $7.35 Million by U.S. Department of Defense for Novel Tuberculosis Interventions
New York (October 7, 2024) – TB Alliance is proud to announce a $7.35 million award through the U.S. Department […]
News
Brazil and Philippines Accelerate Availability of Shorter Drug-Resistant Tuberculosis Treatment
MANILA (September 3, 2024) – A delegation of experts from Brazil’s National TB Program visited Manila recently to collaborate with
New Clinical Trial Examines Use of Novel Compound Telacebec in Buruli Ulcer Patients
NEW YORK (August 21, 2024) – In July 2024, a Phase 2 proof-of-concept study was initiated to explore the use
Ann E. Taylor, MD Joins the TB Alliance Board of Directors
NEW YORK (August, 15, 2024)—TB Alliance is honored to appoint Ann Taylor, MD to its Board of Directors. Welcoming Dr.
New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World
MANILA (25 March 2024)—TB Alliance’s new Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub launched today in Manila, with funding
Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB
CANBERRA (25 March 2024)—The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17
Commitment, Innovation and Action are Needed to End TB — On World TB Day, We Reaffirm our Dedication to all Impacted by Tuberculosis
NEW YORK (March 24, 2024)—Today is World TB Day, the anniversary of when, in 1882, Dr. Robert Koch announced his
Funding for TB and Neglected Diseases Backslides
NEW YORK (January 31, 2024)—The 2023 G-FINDER Report, released today, reveals that funding for neglected disease R&D fell by 10%
News
TB Alliance Launches Five-Country Phase 2 Clinical Trial Evaluating Next-Generation TB Drug
Early results presented at the Union World Conference on Lung Health suggest promise of new compound to fight tuberculosis that
High Cure Rate with Drug-Resistant TB Regimen: Results of Operational Research in Central and Southeast Asia
Indonesia, Kyrgyzstan, Philippines, Ukraine, Uzbekistan, and Vietnam presented results of LIFT-TB operational research program at the Union Conference on Lung